Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetasep (tetacipumab) for adult active dermatomyositis: single-arm exploratory study
ChiCTR2300068866Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Feb 2023
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of telitacicept in dermatomyositis (DM), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Manual muscle testing score. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
telitacicept
03
Conditions
dermatomyositis (DM)
Beyond the preview
Go deeper on ChiCTR2300068866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068866.